Get started
INCYTEINCYTEINCYTE

INCYTE

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

1INCY chart


Full chart

1INCY upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪10.10 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
214.32
Basic EPS (TTM)
0.30 EUR
Net income (FY)
‪31.51 M‬ EUR
Revenue (FY)
‪4.10 B‬ EUR
Shares float
‪190.50 M‬
Beta (1Y)
0.37

Employees


Employees (FY)
‪2.62 K‬
Change (1Y)
+93 +3.68%
Revenue / Employee (1Y)
‪1.57 M‬ EUR
Net income / Employee (1Y)
‪12.04 K‬ EUR

About Incyte Corporation


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Herve Hoppenot
Website
incyte.com
Headquarters
Wilmington
Founded
1991
FIGI
BBG01K3XHTS6
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded on April 8, 1991 and is headquartered in Wilmington, DE.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

1INCY news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Sparks


Curated watchlists where 1INCY is featured.

See all sparks 


Check out other big names from the same industry as 1INCY.

Frequently Asked Questions


The current price of 1INCY is 52.22 EUR — it has increased by 1.99% in the past 24 hours. Watch INCYTE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange INCYTE stocks are traded under the ticker 1INCY.
1INCY stock has fallen by −2.32% compared to the previous week, the month change is a −14.92% fall, over the last year INCYTE has showed a 2.84% increase.
We've gathered analysts' opinions on INCYTE future price: according to them, 1INCY price has a max estimate of 84.01 EUR and a min estimate of 47.48 EUR. Watch 1INCY chart and read a more detailed INCYTE stock forecast: see what analysts think of INCYTE and suggest that you do with its stocks.
1INCY reached its all-time high on Nov 7, 2024 with the price of 79.44 EUR, and its all-time low was 47.34 EUR and was reached on Mar 19, 2025. View more price dynamics on 1INCY chart.
See other stocks reaching their highest and lowest prices.
1INCY stock is 1.95% volatile and has beta coefficient of 0.37. Track INCYTE stock price on the chart and check out the list of the most volatile stocks — is INCYTE there?
Today INCYTE has the market capitalization of ‪10.10 B‬, it has decreased by −2.09% over the last week.
Yes, you can track INCYTE financials in yearly and quarterly reports right on TradingView.
INCYTE is going to release the next earnings report on Apr 29, 2025. Keep track of upcoming events with our Earnings Calendar.
1INCY earnings for the last quarter are 1.38 EUR per share, whereas the estimation was 1.45 EUR resulting in a −5.06% surprise. The estimated earnings for the next quarter are 0.93 EUR per share. See more details about INCYTE earnings.
INCYTE revenue for the last quarter amounts to ‪1.14 B‬ EUR, despite the estimated figure of ‪1.10 B‬ EUR. In the next quarter, revenue is expected to reach ‪912.71 M‬ EUR.
1INCY net income for the last quarter is ‪194.37 M‬ EUR, while the quarter before that showed ‪95.61 M‬ EUR of net income which accounts for 103.29% change. Track more INCYTE financial stats to get the full picture.
No, 1INCY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 15, 2025, the company has ‪2.62 K‬ employees. See our rating of the largest employees — is INCYTE on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INCYTE EBITDA is ‪163.63 M‬ EUR, and current EBITDA margin is 3.99%. See more stats in INCYTE financial statements.
Like other stocks, 1INCY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INCYTE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INCYTE technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INCYTE stock shows the strong sell signal. See more of INCYTE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.